EP3694530A4 - OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

156 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13
Sheet 14
Sheet 15
Sheet 16
Sheet 17
Sheet 18
Sheet 19
Sheet 20
Sheet 21
Sheet 22
Sheet 23
Sheet 24
Sheet 25
Sheet 26
Sheet 27
Sheet 28
Sheet 29
Sheet 30
Sheet 31
Sheet 32
Sheet 33
Sheet 34
Sheet 35
Sheet 36
Sheet 37
Sheet 38
Sheet 39
Sheet 40
Sheet 41
Sheet 42
Sheet 43
Sheet 44
Sheet 45
Sheet 46
Sheet 47
Sheet 48
Sheet 49
Sheet 50
Sheet 51
Sheet 52
Sheet 53
Sheet 54
Sheet 55
Sheet 56
Sheet 57
Sheet 58
Sheet 59
Sheet 60
Sheet 61
Sheet 62
Sheet 63
Sheet 64
Sheet 65
Sheet 66
Sheet 67
Sheet 68
Sheet 69
Sheet 70
Sheet 71
Sheet 72
Sheet 73
Sheet 74
Sheet 75
Sheet 76
Sheet 77
Sheet 78
Sheet 79
Sheet 80
Sheet 81
Sheet 82
Sheet 83
Sheet 84
Sheet 85
Sheet 86
Sheet 87
Sheet 88
Sheet 89
Sheet 90
Sheet 91
Sheet 92
Sheet 93
Sheet 94
Sheet 95
Sheet 96
Sheet 97
Sheet 98
Sheet 99
Sheet 100
Sheet 101
Sheet 102
Sheet 103
Sheet 104
Sheet 105
Sheet 106
Sheet 107
Sheet 108
Sheet 109
Sheet 110
Sheet 111
Sheet 112
Sheet 113
Sheet 114
Sheet 115
Sheet 116
Sheet 117
Sheet 118
Sheet 119
Sheet 120
Sheet 121
Sheet 122
Sheet 123
Sheet 124
Sheet 125
Sheet 126
Sheet 127
Sheet 128
Sheet 129
Sheet 130
Sheet 131
Sheet 132
Sheet 133
Sheet 134
Sheet 135
Sheet 136
Sheet 137
Sheet 138
Sheet 139
Sheet 140
Sheet 141
Sheet 142
Sheet 143
Sheet 144
Sheet 145
Sheet 146
Sheet 147
Sheet 148
Sheet 149
Sheet 150
Sheet 151
Sheet 152
Sheet 153
Sheet 154
Sheet 155
Sheet 156

Every citation, both waysCites: the store holds 3 of 4

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
WO2010120820A1	Cites	World Intellectual Property Organization (WIPO)	Y	Search report	2-6,8-15
WO2015107425A2	Cites	World Intellectual Property Organization (WIPO)	XY	Search report	1
WO2015168618A2	Cites	World Intellectual Property Organization (WIPO)	Y	Search report	8-15

7 members in 5 offices

This recordMember, by publication datePriority claim

Priority claims14

Priority claims
Document	Office	Kind	Date
201762571686	United States of America	P	2017-10-12
201762571686	United States of America	P	2017-10-12
201762571686P	United States of America	–	2017-10-12
201862701078	United States of America	P	2018-07-20
201862701078	United States of America	P	2018-07-20
201862701078P	United States of America	–	2018-07-20
2018055653	United States of America	W	2018-10-12
2018055653	United States of America	W	2018-10-12
201762571686P	–	–	–
201862701078P	–	–	–
US201762571686P	–	–	–
US2018055653	–	–	–
US201862701078P	–	–	–
WO2018US55653	–	–	–

Members7

Family members, oldest first
Document	Office	Kind
WO2019075357A1	World Intellectual Property Organization (WIPO)	A1	2019-04-18
SG11202001783YA	Singapore	A	2020-03-30
EP3694530A1	European Patent Office (EPO)	A1	2020-08-19
JP2020537518A	Japan	A	2020-12-24
EP3694530A4This record	European Patent Office (EPO)	A4	2021-06-30
US2021228615A1	United States of America	A1	2021-07-29
US11596646B2	United States of America	B2	2023-03-07

31 legal events, as 2 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2023-04-26	Application withdrawnWithdrawn18W	18W	EP
2023-03-24	Information on the status of an ep patent application or granted ep patentGrantedSTAA	STAA	EP
2021-06-30	Supplementary search report drawn up and despatchedA4	A4	EP
2021-06-30	Supplementary search report drawn up and despatchedA4	A4	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-06-30	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2021-05-26	Amendment of ipc main classR079	R079	DE
2021-01-20	Request for validation of the european patent (deleted)DAV	DAV	EP
2021-01-20	Request for extension of the european patent (deleted)DAX	DAX	EP
2021-01-20	Request for validation of the european patent (deleted)DAV	DAV	EP
2021-01-20	Request for extension of the european patent (deleted)DAX	DAX	EP
2020-08-19	Request for examination filed17P	17P	EP
2020-08-19	Designated contracting statesAK	AK	EP
2020-08-19	Request for extension of the european patentAX	AX	EP
2020-08-19	Request for examination filed17P	17P	EP
2020-08-19	Designated contracting statesAK	AK	EP
2020-08-19	Request for extension of the european patentAX	AX	EP
2020-07-17	Public reference made under article 153(3) epc to a published international application that has entered the european phasePUAI	PUAI	EP
2020-07-17	Public reference made under article 153(3) epc to a published international application that has entered the european phasePUAI	PUAI	EP
2020-07-17	Information on the status of an ep patent application or granted ep patentGrantedSTAA	STAA	EP
2020-07-17	Information on the status of an ep patent application or granted ep patentGrantedSTAA	STAA	EP
2019-04-19	Information on the status of an ep patent application or granted ep patentGrantedSTAA	STAA	EP
2019-04-19	Information on the status of an ep patent application or granted ep patentGrantedSTAA	STAA	EP

Numbers

Publication: 3694530
Publication, DOCDB: 3694530
Publication, EPODOC: EP3694530
Application: 188659601
Application, DOCDB: 18865960
Application, EPODOC: EP20180865960

Titles3

German: OLIGONUKLEOTIDZUSAMMENSETZUNGEN UND VERFAHREN DAFÜR
English: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
French: COMPOSITIONS D'OLIGONUCLÉOTIDES ET PROCÉDÉS ASSOCIÉS

Classification

CPC, 7: A61K31/7125
C12N15/113
C12N15/111
C12N2310/11
C12N2310/31
C12N2310/351
C12N2320/33
Filled: the office’s first classification
IPC, 5: C12N15 113
A61K31 711
A61K31 712
A61K31 7125
C12Q1 68

Designated states38

Contracting states, 38: Albania
Austria
Belgium
Bulgaria
Switzerland
Cyprus
Czechia
Germany
Denmark
Estonia
Spain
Finland
France
United Kingdom
Greece
Croatia
Hungary
Ireland
Iceland
Italy
Liechtenstein
Lithuania
Luxembourg
Latvia
and 14 moreShow fewer
Monaco
North Macedonia
Malta
Netherlands (Kingdom of the)
Norway
Poland
Portugal
Romania
Serbia
Sweden
Slovenia
Slovakia
San Marino
Türkiye

Oligonucleotide compositions and methods thereof

Abstract

Term